Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Cobo-Calvo

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Neurology|January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 22, 2023
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum DisorderSara Carta, Alessandro Dinoto, Marco Capobianco, et al.
Journal of Neuroinflammation|July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated diseaseAlvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 30, 2025
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum DisorderJavier Villacieros-Álvarez, Maria Sepulveda, Adrián Valls-Carbó, et al.
Brain Communications|July 7, 2025
Deep learning to predict progression independent of relapse activity at a first demyelinating eventLlucia Coll, Deborah Pareto, Francisco Aparicio-Serrano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2023
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patientsRené Carvajal, Carmen Tur, Xavier Martínez-Gómez, et al.
European Journal of Neurology|July 16, 2025
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis PatientsAndreu Vilaseca, Elena Urcelay, Sunny Malhotra, et al.
Annals of Neurology|September 22, 2020
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Neurology|January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 22, 2023
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum DisorderSara Carta, Alessandro Dinoto, Marco Capobianco, et al.
Journal of Neuroinflammation|July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated diseaseAlvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 30, 2025
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum DisorderJavier Villacieros-Álvarez, Maria Sepulveda, Adrián Valls-Carbó, et al.
Brain Communications|July 7, 2025
Deep learning to predict progression independent of relapse activity at a first demyelinating eventLlucia Coll, Deborah Pareto, Francisco Aparicio-Serrano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2023
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patientsRené Carvajal, Carmen Tur, Xavier Martínez-Gómez, et al.
European Journal of Neurology|July 16, 2025
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis PatientsAndreu Vilaseca, Elena Urcelay, Sunny Malhotra, et al.
Annals of Neurology|September 22, 2020
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, et al.
Pageof 5